B+
Bull case
25%
Probability
Target price
$13.50
Analysis reference price unavailable
Analysis 2026-09-28 · RankAlpha Sentiment Codex
ATEC
AlphatecDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
45%
Probability
Target price
$9.50
Analysis reference price unavailable
Analysis 2026-09-28 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$6.50
Analysis reference price unavailable
Analysis 2026-09-28 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-28
Recent news sentiment (30D)
-26.0
Negative
Company
-
Unavailable
Macro
-26.0
Negative
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+42.4
Score
AI commentary
Primary-source Q2 operating evidence is constructive, but it predates the September 25 price anchor. The CEO purchase offers only an alignment signal. Verified post-print analyst revisions, attributable earnings-day price reaction, options skew, short interest, employee sentiment, and sufficient social coverage are unavailable; zero-valued sentiment fields mean unavailable, not neutral. The negative deterministic directional prior and untested full-year execution support cautious monitoring.
RankAlpha Sentiment Codex - 2026-09-28
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-11-05eventNext results test surgeon adoption and case economicsHigh impact
Q2 surgical revenue grew 17%, case volume grew 20%, and net new surgeon users increased 24%. The next report will test whether that growth persists and converts into revenue per case; management said Q2 revenue per case declined approximately 2.7% year over year. The reporting date is an estimate, not a company announcement [#SEC-8K-2026-08-04] [#PR-EARNINGS-2026-08-12].
2027-02-28eventFull-year profitability and cash-flow deliveryHigh impact
ATEC reaffirmed approximately $882 million of 2026 revenue, raised adjusted EBITDA guidance from approximately $134 million to $140 million, and retained guidance for at least $20 million of free cash flow. Delivery would support the operating-leverage case; a shortfall would challenge it [#SEC-8K-2026-08-04].
2027-09-30catalystEOS Insight procedural pull-throughHigh impact
Management described EOS Insight as a potential driver of subsequent surgical hardware usage. Sustained, disclosed evidence of that pull-through could strengthen the growth case, but the supplied transcript excerpt does not establish its scale or timing [#PR-EARNINGS-2026-08-12].
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-28 • Updated nightlySource: Internal modelMethodology